Reuters logo
BRIEF-Sinobioway consortium provides update on Sinovac Biotech acquisition
August 10, 2017 / 10:59 AM / 3 months ago

BRIEF-Sinobioway consortium provides update on Sinovac Biotech acquisition

Aug 10 (Reuters) - Sinovac Biotech Ltd

* Sinobioway consortium provides update on acquiring Sinovac Biotech at the purchase price of $8 per share

* Shandong Sinobioway Biomedicine​ - ‍Sinobioway consortium submitted “restate offer” at $8/share to Sinovac’s board and special committee on June 28, 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below